Barclays’s MaxLinear MXL Stock Holding History

Barclays’s Portfolio MXL Stock Details MXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-1,300	Closed	-$30K	–	7166
2018 Q1	$30K	Buy	1,300 +1,100	+550%	+$27.3K	﹤0.01%	6245
2017 Q4	$5K	Buy	+200	New	+$5K	﹤0.01%	6670

Other funds holding MXL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Barclays's MXL Position: Q2 2026 in Review

Barclays reduced its MaxLinear (MXL) stake by 96% in Q2 2026, selling an estimated $27.3M and leaving 15,215 shares worth $1.95M. The position accounts for ﹤0.01% of the portfolio, ranked #2354.

Barclays first reported a position in MXL in Q2 2013 and has held it in 51 quarters since. The position peaked at $11.2M in Q4 2025. 434 funds tracked by Wall St. Rank hold MXL as of Q2 2026.

Barclays held 15,215 shares of MaxLinear worth $1.95M as of Q2 2026.
Barclays sold 385,844 MaxLinear shares in Q2 2026, an estimated $27.3M.
MaxLinear made up ﹤0.01% of Barclays's portfolio in Q2 2026, its #2354 holding.
Barclays first reported a position in MaxLinear in Q2 2013 and has held it in 51 quarters since.
Barclays's MaxLinear position peaked at $11.2M in Q4 2025.
434 funds tracked by Wall St. Rank held MaxLinear as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.